PN 79164
RN 01144 
AN 80032233
AU Shier-W-T.
TI Increased resistance to influenza as a possible source of
   heterozygote advantage in cystic fibrosis.
SO Med-Hypotheses. 1979 Jun. 5(6). P 661-7.
MJ CYSTIC-FIBROSIS: fg.  HETEROZYGOTE.  ORTHOMYXOVIRUS-INFECTIONS: im.
   PARAMYXOVIRUS-INFECTIONS: im.
MN HUMAN.  IMMUNITY-NATURAL.  INFLUENZA: im.  MEMBRANE-PROTEINS: an.
   SIALIC-ACIDS: an, me.  SIALOGLYCOPROTEINS: an.
AB Cystic fibrosis is the most common lethal or semi-lethal genetic
   disease in Caucasians of Central European origin, among whom it is
   inherited as an autosomal recessive trait at a frequency
   approximately 10 times that expected from recurrent mutation alone. A
   decreased sialic acid content has been observed in cell surface
   glycoproteins on cystic fibrosis fibroblasts and in numerous soluble
   glycoprotein preparations from cystic fibrosis homozygotes. Sialic
   acid residues on cell surface glycoconjugates play an essential role
   in the binding and infectivity of myxoviruses and paramyxoviruses,
   including those causing pandemic influenza. It is suggested that
   increased resistance to these viruses conferred by similar but
   quantitatively smaller alterations in sialoglycoconjugate structure
   in cystic fibrosis heterozygotes may have provided a selective
   advantage to maintain the high frequency of the cystic fibrosis gene
   in Caucasian populations.
RF 001   DI SANTAGNESE PA      N ENGL J MED                   295   481 976
   002   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
   003   CONNEALLY PM          TEX REP BIOL MED                31   639 973
   004   WRIGHT SW             AM J HUM GENET                  20   157 968
   005   HIRSCHHORN K          IN: MANGOS JA                        275 976
   006   ALLISON AC            BR MED J                         1   290 954
   007   HALDANE JBS           HEREDITAS SUPPL                      267 949
   008   STEINBERG AG          AM J HUM GENET                  12   416 960
   009   GAIRDNER D            LANCET                           1   279 975
   010   CRAWFURD MDA          HEREDITY                        29   126 972
   011   STUART AB             LANCET                           2  1521 974
   012   DODGE JA              LANCET                           1   572 975
   013   CRAWFURD MDA          LANCET                           1   167 975
   014   ANDERSON CM           MOD PROBL PEDIATR               10   381 967
   015   DISCHE Z              PEDIATRICS                      24    74 959
   016   ALHADEFF JA           CLIN GENET                      14   189 978
   017   ROELFS RE             AM J DIS CHILD                 113   419 967
   018   MANDEL ID             AM J DIS CHILD                 113   431 967
   019   PEARSON RD            PEDIATR RES                     11   462 977
   020   LAMB D                J PATHOL                        98   213 969
   021   REID L                IN: PORTER R                    32    45 968
   022   POTTER JL             ANN NY ACAD SCI                106   692 963
   023   ALHADEFF JA           CLIN GENET                      13   417 978
   024   SCANLIN TF JR         PEDIATR RES ABST 549            11   463 977
   025   SPIRO RG              ADV PROT CHEM                   27   349 973
   026   GRIMES WJ             BIOCHEMISTRY                    12   990 973
   027   LURIA SE              GENERAL VIROLOGY                     307 967
   028   HIRST GK              J EXP MED                       78    99 943
   029   GOTTSCHALK A          YALE J BIOL MED                 26   352 954
   030   LEICHTENSTERN O       INFLUENZE UND DENGUE                     896
   031   STUART-HARRIS CH      INFLUENZA THE VIRUSES AND DIS            976
CT   1   BURNET M              PERSPECT BIOL MED               24   511 981